ByTrending Posts
How RevolKa’s $1.7M Series A Extension Fuels AI-Driven…
Sendai, Japan – May 20, 2025 RevolKa Ltd., a fast-growing biotechnology company leveraging AI for protein engineering, has…
Foxconn and NVIDIA: How Can AI-Driven Robotics Address…
May 18, 2025 In response to the World Health Organization’s projection of a 4.5 million nurse shortage by…
Is Quantum AI the Future of RNA Drug…
Key Highlights: INDIANAPOLIS, IN & SAN DIEGO, CA – In a major signal of the industry’s growing confidence…
Johnson & Johnson MedTech and Qure.ai Partner to…
May 10, 2025 – IndiaJohnson & Johnson MedTech has announced a strategic collaboration with healthcare AI innovator Qure.ai…
Can Eli Lilly and Purdue University reshape pharmaceutical…
The initiative will focus on applying artificial intelligence, robotics, and data science to improve every stage of the…
AI-driven ALS therapy: How Eli Lilly is expanding…
Key highlights AI-powered discovery enters clinical stageEli Lilly and Company has entered into a licensing agreement with Alchemab…
How Are Eli Lilly & BigHat Biosciences Using…
Key highlights San Mateo, CA – BigHat Biosciences, a biotechnology company applying machine learning to antibody design and…
How Is Medtronic Transforming Stroke Care with Methinks…
Medtronic and Methinks AI Collaborate to Revolutionize Early Stroke Detection and Treatment Portage, Michigan – April 2, 2025…
Can AstraZeneca’s $2.5B Beijing Bet Mark a New…
Key Highlights A $2.5B Strategic Move to Strengthen Global R&D Leadership AstraZeneca has announced a $2.5 billion strategic…
Trending Posts
Latest Stories
Can Dual Regulatory Approvals Position UltraGreen.ai as a Regional Leader in Fluorescence-Guided and AI-Enabled Surgery in Southeast Asia?
Singapore – December 31, 2025 — UltraGreen.ai Limited, a Singapore-based company specializing in fluorescence-guided surgery…
What Does SoftBank’s $41 Billion Bet on OpenAI Signal for the Future of Biopharma, Healthcare, and AI Infrastructure?
Global – December 2025 — SoftBank’s $41 billion investment in OpenAI represents one of the…
Did Ophthalmic Therapy Approvals in 2025 Redefine Vision Care—and Set the Stage for Accelerated Innovation in 2026?
Global – December 2025 — The ophthalmology therapeutic area entered a renewed phase of innovation…
Did Metabolic Therapy Approvals in 2025 Reset the Standard of Care—and Ignite a New Growth Cycle in 2026?
Global – December 2025 — The metabolic therapeutic area emerged as one of the most…
Gallery
